Aqr Capital Management LLC Prelude Therapeutics Inc Transaction History
Aqr Capital Management LLC
- $151 Billion
- Q3 2025
A detailed history of Aqr Capital Management LLC transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 10,500 shares of PRLD stock, worth $16,065. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,500
Previous 43,647
75.94%
Holding current value
$16,065
Previous $35,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRLD
# of Institutions
47Shares Held
28MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$16.7 Million0.5% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$15.5 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.15MShares$1.75 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$1.64 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA993KShares$1.52 Million0.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $55.6M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...